Search clinical trials for: (Epirubicin Cyclophosphamide - Docetaxel) (Trastuzumab Pertuzumab)
Total 751 results
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
German Breast GroupAGO Study GroupCompleted
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Shengjing HospitalRecruitingStage II-III Breast CancerChina
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerUnited States, Italy, United Kingdom, Australia, Austria, Belgium, Brazil, Denmark, France, Guatemala, Korea, Republic of, Portugal, Spain, Turkey, Colombia, Canada, Czechia, Japan, Poland, Romania, Russian Federation, Switzerland, ... and more
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Shengjing HospitalNot yet recruiting
-
Jules Bordet InstituteSanofiTerminated
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
Fudan UniversityCompleted
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Fudan UniversityRecruiting
-
Accelerated Community Oncology Research NetworkAventis PharmaceuticalsCompletedBreast NeoplasmUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Zhejiang Provincial People's HospitalNot yet recruitingBreast Cancer | Chemotherapy Effect
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
Translational Research Center for Medical Innovation...Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Fudan UniversityChinese Anti-Cancer AssociationCompleted
-
Georgetown UniversityRecruitingNon-metastatic Breast Cancer | Cancer Related Cognitive DeclineUnited States
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Hospices Civils de LyonNot yet recruiting
-
German Breast GroupCompleted
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Fujian Medical University Union HospitalRecruiting
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, Turkey, United Kingdom, Kenya, Hungary, Poland, Colombia, India, Oman, Uganda, United Arab... and more
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Genentech, Inc.Approved for marketing
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
Hoffmann-La RocheActive, not recruiting
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
Danish Breast Cancer Cooperative GroupSanofi; Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning; DakoCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Vejle HospitalCompleted
-
Guangdong Provincial People's HospitalFirst Affiliated Hospital, Sun Yat-Sen University; Henan Cancer Hospital; Dongguan... and other collaboratorsCompleted
-
Hebei Medical University Fourth HospitalUnknownStage III Breast CancerChina
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaboratorsUnknown
-
Shanghai Jiao Tong University School of MedicineTerminated